Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy.
Valent
P
P
First Medical Department, University of Vienna, Austria.
Sillaber
C
C
Geissler
K
K
Andreeff
M
M
Tafuri
A
A
Vieder
L
L
Schulz
G
G
Lechner
K
K
Bettelheim
P
P
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000628:therapy*; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects; D011994:Recombinant Proteins / Q000627:therapeutic use; D012074:Remission Induction
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor